Hercules Capital Inc (HCXY) is a leading and highly-specialized finance company dedicated to providing venture debt capital to innovative, venture capital-backed companies across a wide range of sectors and stages. With its vast industry experience and venture financing capabilities, Hercules Capital has carved out its unique niche by employing a value-added, disciplined investment approach that ensures optimized strategic advantage and sustainable returns for shareholders.
Established in 2003, the Palo Alto-based company has grown to be a trusted player in the industry. Its focus on venture lending products at all stages of growth and expansion helps companies achieve critical milestones while minimizing dilution and creating enterprise value. Hercules Capital’s impressive portfolio covers various growth industries including technology, life sciences, renewable energy and special situations.
Through HCXY, its publicly-traded bond, Hercules Capital raises capital for its investment activities. The bond provides individual investors with an opportunity to invest in a liquid, interest-bearing security that has a steady stream of income, and is backed by a well-diversified portfolio of venture debt investments in innovative growth companies.
Hercules has a uniquely flexible and responsive approach to venture lending. The company operates with a team of seasoned professionals providing guidance and resources to client companies. It offers customized financing solutions, advisory services, flexible funding structures, and value-added services such as network introductions and board representation.
Through dynamic and responsible investing, Hercules Capital has distinguished itself as one of the leading specialty finance companies serving both public and private companies backed by leading venture capital and private equity firms. The company has built a strong track record of success and commitment to its partners by providing flexible growth capital to companies within their portfolio.
The philosophy at Hercules Capital centers on the belief in creating innovative financial solutions tailored to the unique needs of burgeoning companies across versatile sectors. Offering a range of financial structures and packages, Hercules Capital adopts a collaborative approach, working closely with the company’s management and board to identify the most optimal solution for their capital needs.
In summary, Hercules Capital is a company dedicated to fostering growth for venture-backed enterprises through its extensive suite of financial services. With a focus on collaboration and innovation, it continues to be a driving force in the landscape of venture capital-backed industries.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Atea Pharmaceuticals has secured a credit facility worth up to $200 million from Hercules Capital, with an initial $65 million received at closing. This non-dilutive financing aims to strengthen Atea's financial position and provide operational flexibility as it advances its late-stage clinical programs, including the anticipated launch of its hepatitis C virus (HCV) treatment. The funding will support the company's efforts towards key clinical and regulatory milestones, with a planned new drug application (NDA) submission in mid-2027 and potential US commercial launch in 2028.
Rocket Pharmaceuticals has secured a senior secured term loan facility of up to $150 million from Hercules Capital, with an initial draw of $35 million. The agreement, finalized on September 30, 2026, also involves the issuance of warrants to lenders for the purchase of up to 1,755,853 common stock shares at an exercise price of $2.99 each. This financing aims to support the company's operations with a floating interest rate and a maturity date of October 1, 2030, with potential extensions.
Hercules Capital, Inc. has received an affirmed investment grade corporate and credit rating of BBB+ from Kroll Bond Rating Agency, Inc. (KBRA). This rating reflects the company's diversified investment portfolio, strong operating history spanning over 23 years, and appropriate leverage metrics. KBRA highlighted Hercules Capital's robust risk management, experienced investment team, and proven access to capital markets as key factors supporting the favorable rating and stable outlook.